Suggestions
Patrick Gomez Menzies, MS, MBA
Commercial Leader | Market Access | Driving Innovation for Patients
Patrick Gomez Menzies, MS, MBA is a life sciences and pharmaceutical professional with over 13 years of experience in the industry.1 He currently serves as the Director of Market Access at Chiesi USA, Inc., a position he started in March 2024.2
Professional Background
Patrick has a strong background in driving innovation and commercialization in the pharmaceutical sector. His expertise spans various areas, including:
- Commercial strategy and execution
- Launch excellence
- Marketing
- Market access
- R&D planning
- Start-up funding
He has applied his knowledge and experience to lead pharmaceutical, biotech, and health IT companies over the past 6+ years.1
Education and Research
Patrick holds both an MS and an MBA, with part of his education completed at Harvard University.1 Before transitioning to the commercial side of the industry, he spent 7+ years in biomedical research, focusing on:
- Genetics/genomics
- Biochemistry
- Molecular and cell biology
His research areas included cardiovascular diseases, oncology, and infectious diseases.1
Career Highlights
- Currently involved in launching the first CRISPR gene therapy for patients1
- Previously worked on oncology commercial strategy and execution1
- Embedded in healthcare innovation with Action Potential Venture Capital3
Awards and Recognitions
Throughout his academic and professional career, Patrick has received numerous awards and fellowships, including:
- Goldman Sachs Scholar (2000)
- Jack Kent Cooke Foundation Scholar (2004)
- National Merit Commended Scholar (2006)
- Howard Hughes Medical Institute Gilliam Fellowship for Advanced Study (2015)
- The Consortium for Graduate Study in Management Fellow (2017)
- Richard H. Jenrette MBA Fellow (2017)
Patrick has also received multiple GSK Global Recognition Awards during his time at GlaxoSmithKline.1
Patrick Gomez Menzies is passionate about making an impact on patients' quality of life worldwide through healthcare innovation and commercialization of new technologies and treatments.1
